ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETASONE AND DARATUMUMAB OR BORTEZOMIB IN MULTIPLE RECYCLING / REFRACTORY MYELOMA (MMRR) TO AN IMMUNOMODULATOR AND/OR A PROTEASOMA INHIBITOR (IP): UPDATE OF EFFECTIVENESS AND SAFETY
HAEMATOLOGICA（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要